CRSP
$93.41
Crispr Therapeutics Ag
$.76
.82%
CRSP
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($1.17)
Revenue:  $3.96 Mil
Monday
Nov 2
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CRSP reports earnings?
Beat
Meet
Miss

Where is CRSP's stock price going from here?
Up
Flat
Down
Stock chart of CRSP
Analysts
Summary of analysts' recommendations for CRSP
Score
Grade
Pivots
Resistance
$99.88
$96.38
$94.52

$91.02

Support
$89.15
$85.65
$83.79
Tweet
Growth
Description
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.